News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Luis E Raez: Memorial Cancer Institute’s 2024 Annual Best of ASCO is coming in July
Photo from Luis E Raez/LinkedIn
May 27, 2024, 14:37

Luis E Raez: Memorial Cancer Institute’s 2024 Annual Best of ASCO is coming in July

Luis E Raez, Medical Director at Memorial Cancer Institute, shared on their LinkedIn:

”Memorial Cancer Institute’s 2024 Annual Best of ASCO is coming in July!!! Save the date July12-13th at the JW Marriott Marquis in Miami. Lung cancer with H.Lee Moffitt Cancer Center and Florida Atlantic University (FAU).”

Luis E Raez

Source: Luis E Raez/LinkedIn

ASCO cancer FAU Florida Atlantic University lcdm Luis E. Raez Lung cancer Memorial Cancer Institute OncoDaily Oncology
Special Coverage
Blog
Jan 15, 2025, 16:37
Survivorship webinar by SIOP International - Childhood Cancer International
Blog
Jan 15, 2025, 16:31
An excerpt from the just-concluded Conversations on Cancer panel discussion - FDA Oncology
Insight
Jan 15, 2025, 16:26
An IGG gene signature links to longevity in breast cancer survivors - ESMO Open
Blog
Jan 15, 2025, 16:21
Zainab Shinkafi-Bagudu: Excited to introduce "Learning Tuesday with Dr. ZSB"
Insight
Jan 15, 2025, 16:20
Liquid Biopsy Breakthrough - International Society of Liquid Biopsy
Blog
Jan 15, 2025, 16:16
Monica Bertagnolli is ending her tenure as NIH director
Blog
Jan 15, 2025, 16:15
Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment
Insight
Jan 15, 2025, 16:13
Nihar Desai: A case of elevated white cell count in a 60-year-old male
Blog
Jan 15, 2025, 16:11
Megan-Claire Chase: Attending the Stand Up for Trans Georgians Rally
Positive
Jan 15, 2025, 15:57
William Pao: Breakthrough - The Quest for Life-Changing Medicines
Science
Jan 15, 2025, 15:32
Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Insight
Jan 15, 2025, 15:27
Sylvester Study Highlights Global Trends in Lung Cancer Risk Factors: Tobacco, Pollution, and Asbestos